Cargando…

The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline

Percutaneous coronary intervention (PCI), the most common method in treating coronary artery disease (CAD), has a variety of side effects. Yiqi Huoxue therapy (YQHX) can effectively alleviate the symptoms of patients and reduce the side effects. However, a reliable and systematic assessment of the m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Miao, Sun, Ming-Yue, Chen, Qi-Ting, Xu, Feng-Qin, Chen, Zong-Zheng, Wei, Wen-Bo, Wang, Rui-Ting, Xu, Gui-Peng, Yin, Hui-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575818/ https://www.ncbi.nlm.nih.gov/pubmed/36254054 http://dx.doi.org/10.1097/MD.0000000000030739

Ejemplares similares

The efficacy of Yiqi Huoxue therapy for chronic heart failure: A meta-analysis in accordance with PRISMA guideline
por: Zhang, Miao, et al.
Publicado: (2022)

Mechanism of Yiqi Huoxue Huatan recipe in the treatment of coronary atherosclerotic disease through network pharmacology and experiments
por: Huang, Hong-Tao, et al.
Publicado: (2023)

A retrospective study of Yiqi-Huoxue Decoction on blood pressure in patients with acute ischemic stroke
por: Jiang, Chao, et al.
Publicado: (2020)

Effect of Yiqi Huoxue Granules on Platelet Activation Induced by Thrombin
por: Lei, Zhen, et al.
Publicado: (2021)

Yiqi Huoxue Recipe Delayed Intervertebral Disc Degeneration by Activating Autophagy
por: Dai, Feng, et al.
Publicado: (2021)

Yiqi Huoxue preserves heart function by upregulating the Sigma-1 receptor in rats with myocardial infarction
por: Lou, Lixia, et al.
Publicado: (2021)

Efficacy and safety of Yiqi Huoxue Yangxin decoction combined with western medicine in patients with chronic coronary heart disease: A protocol for systematic review and meta-analysis
por: Xie, Bingxin, et al.
Publicado: (2022)

Yiqi Yangyin Huoxue Method in Treating Diabetic Retinopathy: A Systematic Review and Meta-Analysis
por: Ou, Chen, et al.
Publicado: (2019)

Yiqi Huoxue Recipe Improves Liver Regeneration in Rats after Partial Hepatectomy via JNK Pathway
por: Li, Wen-cong, et al.
Publicado: (2020)

A Meta-Analysis of Randomized Controlled Trials of Yiqi Yangyin Huoxue Method in Treating Diabetic Nephropathy
por: Ou, Jiao Ying, et al.
Publicado: (2016)

Effects of Yiqi Huoxue Decoction on Post-Myocardial Infarction Cardiac Nerve Remodeling and Cardiomyocyte Hypertrophy in Rats
por: Wang, Hui, et al.
Publicado: (2021)

Integrated UPLC-MS and Network Pharmacology Approach to Explore the Active Components and the Potential Mechanism of Yiqi Huoxue Decoction for Treating Nephrotic Syndrome
por: Feng, Dan, et al.
Publicado: (2022)

Impact of Yiqi Huoxue Decoction on the Relationship between Remodeling of Cardiac Nerves and Macrophages after Myocardial Infarction in Rats
por: Liu, Yunke, et al.
Publicado: (2022)

Effect of sitagliptin combined with Yiqi yangyin huoxue decoction on clinical efficacy and hemorheology in early diabetic nephropathy
por: Ling, Jun, et al.
Publicado: (2023)

Yiqi Yangyin Huoxue Method in Treating IdiopathicPulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Zhou, Min, et al.
Publicado: (2020)

Yiqi Huoxue Tongluo recipe regulates NR4A1 to improve renal mitochondrial function in unilateral ureteral obstruction (UUO) rats
por: He, Zhen, et al.
Publicado: (2022)

Retracted: Impact of Yiqi Huoxue Decoction on the Relationship between Remodeling of Cardiac Nerves and Macrophages after Myocardial Infarction in Rats
por: Healthcare Engineering, Journal of
Publicado: (2023)

The effect of Huoxue Huayu decoction on restenosis after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Hou, Yi, et al.
Publicado: (2022)

Yiqi Huoxue Recipe inhibits cardiomyocyte apoptosis caused by heart failure through Keap1/Nrf2/HIF-1α signaling pathway
por: Hu, Ling, et al.
Publicado: (2021)

Yiqi Huoxue Recipe Improves Heart Function through Inhibiting Apoptosis Related to Endoplasmic Reticulum Stress in Myocardial Infarction Model of Rats
por: Lou, Li-Xia, et al.
Publicado: (2014)

Yiqi-Huoxue Granule (YQHX) Downregulates Prothrombotic Factors by Modulating KLF2 and NF-κB in HUVECs following LPS Stimulation
por: Wu, Hong, et al.
Publicado: (2019)

Whole-transcriptome sequencing analysis reveal mechanisms of Yiqi Huoxue Yangyin (YHY) decoction in ameliorating D-gal-induced cardiac aging
por: Wang, Xue, et al.
Publicado: (2023)

Efficacy of Yiqi Wenyang Huoxue method in treating adult bronchial asthma: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Yu, Qiangqiang, et al.
Publicado: (2022)

Huoxue Qingre decoction used for treatment of coronary heart disease network analysis and metabolomic evaluation
por: Tan, Yu-Qing, et al.
Publicado: (2022)

Are the guidelines for coronary artery revascularization, according to the syntax score, being correctly applied, by a heart team?
por: Almeida, Rui, et al.
Publicado: (2015)

Left Main Coronary Artery Percutaneous Coronary Intervention
por: Ferrante, Arnaud, et al.
Publicado: (2022)

The Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention
por: Zhang, Da-Peng, et al.
Publicado: (2020)

Percutaneous coronary intervention for ostial lesions of the left main stem in a patient with congenital single left coronary artery: A case report
por: Wu, Qiang, et al.
Publicado: (2019)

Yiqi Huoxue Recipe Regulates Autophagy through Degradation of Advanced Glycation End Products via mTOR/S6K1/LC3 Pathway in Diabetic Nephropathy
por: Chen, Liang, et al.
Publicado: (2021)

Coronary magnetic resonance angiography of coronary artery total occlusion: imaging findings and success rates of percutaneous coronary intervention according to intraluminal signal intensity patterns
por: Kim, Sung Mok, et al.
Publicado: (2014)

The Effectiveness and Safety of Bushen Huoxue Decoction on Treating Coronary Heart Disease: A Meta-Analysis
por: Liu, Lan-Chun, et al.
Publicado: (2021)

Coronary artery bypass grafting vs. percutaneous coronary intervention in coronary artery disease patients with advanced chronic kidney disease: A Chinese single-center study
por: Li, Yang, et al.
Publicado: (2023)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Wu, Ting-Ting, et al.
Publicado: (2019)

Retrospective analysis of exercise capacity in patients with coronary artery disease after percutaneous coronary intervention or coronary artery bypass graft
por: Li, Ying, et al.
Publicado: (2021)

Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting for the Treatment of Left Main Coronary Artery Disease
por: Cho, Sang-Cheol, et al.
Publicado: (2019)

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
por: Jia, Si-Da, et al.
Publicado: (2020)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

The Effect of Yiqi Huoxue Tongluo Decoction on Spinal Cord Microglia Activation and ASK1-MKK3-p38 Signal Pathway in Rats with Diabetic Neuropathic Pain
por: Wang, Fanjing, et al.
Publicado: (2022)

Hybrid coronary revascularization vs. percutaneous coronary interventions for multivessel coronary artery disease
por: Hannan, Edward L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_95qhe8308j6ti8ioqc75la09mf